OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MAVS: A Two-Sided CARD Mediating Antiviral Innate Immune Signaling and Regulating Immune Homeostasis
Yunqiang Chen, Yuheng Shi, Jing Wu, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Mitochondria in health, disease, and aging
John S. Harrington, Stefan W. Ryter, Maria Plataki, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2349-2422
Open Access | Times Cited: 261

MAVS integrates glucose metabolism and RIG-I-like receptor signaling
Qiao-qiao He, Yu Huang, Longyu Nie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22

Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide
Xiao Xiao, Yanan Fu, Wanling You, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 5

Identification and Characterization of a Novel Rat MAVS Variant Modulating NFκB Signaling
İhsan Nalkıran, Hatice Sevim Nalkıran
Biomolecules (2025) Vol. 15, Iss. 1, pp. 139-139
Open Access

Aggregatin is a mitochondrial regulator of MAVS activation to drive innate immunity
Ju Gao, Mao Ding, Yan‐Bin Xiyang, et al.
The Journal of Immunology (2025)
Closed Access

The Essential Role of Mitochondrial Dynamics in Viral Infections
Xujie Duan, Rui Liu, Wenjun Lan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1955-1955
Open Access

MicroRNAs in the Mitochondria–Telomere Axis: Novel Insights into Cancer Development and Potential Therapeutic Targets
José Alfonso Cruz-Ramos, Emmanuel De La Mora-Jiménez, Beatriz Alejandra Llanes-Cervantes, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 268-268
Open Access

A targeted MAVS fusion protein for controlled innate immune activation and antitumor therapy
Muhan Wang, Zhijie Zhang, Yanwei Yang, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access

Connection Between HIV and Mitochondria in Cardiovascular Disease and Implications for Treatments
Antentor Hinton, Alhaji U. N’jai, Zer Vue, et al.
Circulation Research (2024) Vol. 134, Iss. 11, pp. 1581-1606
Open Access | Times Cited: 4

SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms of impairment on host antiviral immunity and therapeutic approaches
Mingming Wang, Yue Zhao, Juan Liu, et al.
MedComm – Future Medicine (2022) Vol. 1, Iss. 2
Open Access | Times Cited: 16

Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
Meng–Huang Wu, Zhiyin Pei, Guangfeng Long, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10

Clinical efficacy, pharmacodynamic components, and molecular mechanisms of antiviral granules in the treatment of influenza: A systematic review
Juan Su, Xinming Chen, Yi-ling Xie, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117011-117011
Closed Access | Times Cited: 9

Viruses and Mitochondrial Dysfunction in Neurodegeneration and Cognition: An Evolutionary Perspective
George B. Stefano, Simon Weissenberger, Radek Ptáček, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3

Overexpression of the mitochondrial anti-viral signaling protein, MAVS, in cancers is associated with cell survival and inflammation
Sweta Trishna, Avia Lavon, Anna Shteinfer‐Kuzmine, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 33, pp. 713-732
Open Access | Times Cited: 8

Dengue Virus 2 NS2B Targets MAVS and IKKε to Evade the Antiviral Innate Immune Response
Ying Nie, Dongqing Deng, Lumin Mou, et al.
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 5, pp. 600-606
Open Access | Times Cited: 7

Enhanced in vivo antiviral activity against pseudorabies virus through transforming gallic acid into graphene quantum dots with stimulation of interferon-related immune responses
Shiyi Ye, Fei Su, Junxing Li, et al.
Journal of Materials Chemistry B (2023) Vol. 12, Iss. 1, pp. 122-130
Closed Access | Times Cited: 7

Fufang Luohanguo Qingfei granules reduces influenza virus susceptibility via MAVS-dependent type I interferon antiviral signaling
Yu-Hui Lu, Min Wang, Jiuxiu Lin, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117780-117780
Closed Access | Times Cited: 2

MAVS Ubiquitylation: Function, Mechanism, and Beyond
Hongliang Dong, Jie Shen
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 2

Post-Acute Sequelae And Mitochondrial Aberration In SARS-CoV-2 Infection
Charles O. Ward, Beata Schlichtholz
(2024)
Open Access | Times Cited: 2

The Hemagglutinin of Influenza A Virus Induces Ferroptosis to Facilitate Viral Replication
Aotian Ouyang, Tong Chen, Yi Feng, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 2

Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses
Liqiu Wang, Mengqiu Li, Guang‐Yu Lian, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 23
Closed Access | Times Cited: 2

MAVS: The Next STING in Cancers and Other Diseases
Xichen Wang, Qingwen Wang, Chunfu Zheng, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104610-104610
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top